5 Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Medicare does not currently cover GLP-1s for weight loss alone only for diabetes, cardiovascular disease, or sleep apnea but a GLP-1 demonstration program for obesity is expected to begin in mid-2026 for some Medicare enrollees
If you are looking for broader nutrition ideas that can support your routine, this guide on what supplements help with weight loss is a helpful place to start
Most peptides retain 90-95% potency at 28 days, dropping to 80-85% by 60 days
Case identification was performed through drug name queries in the DRUG table, with subsequent filtering restricted to Primary Suspect (PS) cases